Current Perspectives on Echinocandin Class Drugs

Cited by (276)

Items 201–276 of 276

1. In vitro determination of antifungal susceptibility and virulence factors in Candida species causing candidemia in North India Region
   Punit Tiwari, Aishwarya Nikhil, Khushi Tiwari, Tanushree Paonikar, Munesh Kumar Gupta, Ragini Tilak · 2024 · Discover Public Health
2. A review of the fernane-type triterpenoids as anti-fungal drugs
   Chunyue Liu, Lu Zhang, Si-Xuan Liu, Yong‐Fu Lu, Chang Li, Yue‐Hu Pei · 2024 · Frontiers in Pharmacology
3. Synthesis and Anticandidosic Activities of Some 3-Imidazo[1,2-a]Pyridinyl-1-Arylpropenone Derivatives
   Adingra Francesco Kouassi, Souleymane Coulibaly, Kacou Alain, Mahama Ouattara, Drissa Sissouma · 2022 · Advances in Biological Chemistry
4. The novel antifungal agent AB-22 displays in vitro activity against hyphal growth and biofilm formation in Candida albicans and potency for treating systemic candidiasis
   Kyung-Tae ‍Lee, Dong‐Gi Lee, Ji‐Won Choi, Jong‐Hyun Park, Ki Duk Park, Jong-Seung Lee, Yong‐Sun Bahn · 2022 · The Journal of Microbiology
5. Identification of Fungicide Targets in Pathogenic Fungi
   Andrew J. Foster, Eckhard Thines · 2009 · Springer eBooks
6. Myc(et)obiome: The Big Uncle in the Family
   Manousos E. Kambouris, Aristea Velegraki · 2020 · Elsevier eBooks
7. Identification of Fungicide Targets in Pathogenic Fungi
   Andrew J. Foster · 2018 · Springer eBooks
8. A host defense peptide mimetic, brilacidin, potentiates caspofungin antifungal activity against human pathogenic fungi
   Thaila Fernanda dos Reis, Patrícia Alves de Castro, Rafael Wesley Bastos, Camila Figueiredo Pinzan, Pedro Filho Noronha Souza, Suzanne Z. Ackloo, Mohammad Anwar Hossain, David Harold Drewry, Sondus Alkhazraji, Ashraf S. Ibrahim et al. · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
9. The Putative Cytochrome b5 Domain-Containing Protein CaDap1 Homologue Is Involved in Antifungal Drug Tolerance, Cell Wall Chitin Maintenance, and Virulence in Candida albicans
   Dayong Xu, Manman Wang, Xing Zhang, Hongchen Mao, Haitao Xu, Biao Zhang, Xin Wu Zeng, Feng Li · 2024 · Journal of Fungi
10. Bioactive potential of Eugenia luschnathiana essential oil and extract: antifungal activity against Candida species isolated from oncological patients
    Palloma Christine Queiroga Gomes da Costa, Paula Lima Nogueira, Yuri Mangueira do Nascimento, Marianna Vieira Sobral, Geovana Ferreira Guedes Silvestre, Ricardo Dias de Castro · 2024 · Brazilian Journal of Biology
11. Are Echinocandins Better Than Azoles for Invasive Candidiasis?
    Sanjay G. Revankar, Jack D. Sobel · 2012 · Current Fungal Infection Reports
12. The current place of echinocandins in the treatment and prophylaxis of invasive fungal infections
    Alexander V. Veselov · 2020 · Clinical Microbiology and Antimicrobial Chemotherapy
13. Candida Biofilm: Clinical Implications of Recent Advances in Research
    Ellen G. Press, Ryan K. Shields, Cornelius Joseph Clancy · 2014 · Current Fungal Infection Reports
14. Role of Antifungal Drugs in Combating Invasive Fungal Diseases
    Kakoli Dutt · 2019 · Wiley eBooks
15. Antifungal Drug Resistance
    Johanna L. Rhodes · 2025 · Current topics in microbiology and immunology
16. Decoding the Structural Complexity of Fungal α‐ and β‐Glucan Matrix via Statistical Analysis of Solid‐State NMR Chemical Shifts
    Ankur Ankur, Cameron S. Vojvodin, Debkumar Debnath, Tuo Wang · 2026 · Israel Journal of Chemistry
17. Bioactive Potential of Streptomyces Spp. Against Diverse Pathogenic Fungi
    Harsha Harsha, Munendra Kumar, Prateek Kumar, Renu Solanki, Monisha Khanna Kapur · 2024 · Springer eBooks
18. Prevalence and molecular basis of resistance to echinocandins among clinical Candida glabrata isolates in Guangdong province, China
    Lin, Weihong, Peng, Yaqin, Xiang, Bo, Fang, Jingchun, Ye, Junkai, Guo, Penghao · 2025 · BMC Microbiology
19. Host-Fungal Interactions: Pathogenicity versus Immunity
    Arianna Tavanti, Julian R. Naglik, Nir Osherov · 2012 · International Journal of Microbiology
20. Presence of L701 M mutation in the FKS1 gene of echinocandin-susceptible Candida krusei isolates
    Fabiola Lallitto, Anna Prigitano, Francesca Mangione, Antonio Piralla, Francesca Tamarozzi, P. Marone, Caterina Cavanna · 2018 · Diagnostic Microbiology and Infectious Disease
21. Frontier in Antifungal Treatments Against Major Human Fungal Opportunistic Pathogen Candida Species and Medically Important Fungi
    Nitnipa Soontorngun, Pichayada Somboon, Kwanruthai Watchaputi · 2019 · Springer eBooks
22. Structural and Biophysical Dynamics of Fungal Plasma Membrane Proteins and Implications for Echinocandin Action in Candida glabrata
    Jennifer Bo Jiang, Mikhail V. Keniya, Anusha Puri, Xueying Zhan, Jeff Cheng, Huan Wang, Gigi Lin, Yun-Kyung Lee, Nora Jaber, Yasmine Hassoun et al. · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
23. Prevalent fungal pathogens and antifungal resistance in Lebanon: A scoping review
    Yara Khachab, Majd Bou Ghader, Vera Tahesh, Racha Khoumassi, Elie Salem Sokhn · 2025 · Journal of Infection and Public Health
24. Draft genome sequences of two clinical isolates of Candida tropicalis from Iraq
    Wafaa S. H. AL-Nasrawi, Ban Taha Mohammed, Adnan A. Lahuf · 2025 · Microbiology Resource Announcements
25. Lippia sidoides essential oil against Candida auris and Candida albicans – A promising strategy for antifungal activity in the context of oral candidiasis
    G Sivieri Araujo, Isabel Cristina Torres Alves de Jesus, Palloma Christine Queiroga Gomes da Costa, Karinne Kelly Gadelha Marques, Juan Carlos Ramos Gonçalves, Ricardo Dias de Castro · 2026 · Archives of Oral Biology
26. Safety and efficacy of echinocandin antifungal agents in Candida albicans endophthalmitis
    Yue Zhang, Y R Tang, Yanjie Zhou, Hong Wu · 2026 · Antimicrobial Agents and Chemotherapy
27. Targeting Fungal Adaptive Networks and Emerging Molecular Targets for Next-Generation Antifungal Therapeutics
    Conrad Chibunna Achilonu · 2026 · Drugs and Drug Candidates
28. Antifungal effects of echinocandins diminish when exposed to intestinal lumen contents: a finding with potentially significant clinical implications
    Sepideh Mehravar, Gabriela S. Leite, Mark Pimentel, Ali Ranjideh Rezaie · 2024 · Frontiers in Pharmacology
29. Antifungal Resistance in Candida albicans
    Sima Sadat Seyedjavadi, Farahnaz Hatami, Zahra Jahanshiri · 2024 · IntechOpen eBooks
30. The Role of Resistance in Candida Infections: Epidemiology and Treatment
    Jack D. Sobel, Robert A. Akins · 2009 · Humana Press eBooks
31. Development of an in vitro pharmacokinetic/pharmacodynamic model in the presence of serum for studying micafungin activity against Candida albicans: a need for revision of CLSI susceptibility breakpoints
    Maria-Ioanna Beredaki, Maiken Cavling Arendrup, David R. Andes, Joseph Meletiadis · 2023 · Journal of Antimicrobial Chemotherapy
32. BACTERIAL PROTEINS WITH ANTI-CANDIDA PROPERTY AND THEIR MODE OF ACTION: A REVIEW.
    Meora Rajeev, Vikrant Palande, Bharati Vidyapeeth · 2015
33. Micafungin injection for the treatment of invasive candidiasis in pediatric patients under 4 months of age
    Nahed Abdel‐Haq, Stephanie M. Smith, Basim I. Asmar · 2021 · Expert Review of Anti-infective Therapy
34. Antifungals
    David S. Perlin · 2017 · Springer eBooks
35. The Cell Wall of Medically Relevant Yeasts and Molds
    Manuela Gómez-Gaviria, Laura Cristina García-Carnero, Alma Karina Tamez-Castrellón, Hector Manuel Mora-Montes · 2021 · Elsevier eBooks
36. Mechanisms of Resistance to Antifungal Agents
    David S. Perlin · 2023 · ClinMicroNow
37. Evaluation of the efflux inhibitory potential of aminopyrazole derivative to restore azole sensitivity in Candida albicans
    Vineetha K Unnikrishnan, Niranjana Sri Sundaramoorthy, Ramaravinth Manivannan, Markabandhu Shanthi, Divya Prakash Gnanadhas, Soundarya Priya Alexandar, Venkatasubramanian Ulaganathan, Subburethinam Ramesh, Saisubramanian Nagarajan · 2025 · Bioorganic & Medicinal Chemistry Letters
38. The siderophore transporter Sit1 is involved in the uptake of caspofungin by Candida albicans
    Andreia Pedras, Catarina Amaral, Cristiano Conceição, Cláudia Malta-Luís, Teresa Pissarro, Carolina V. Mariano, Oscar A. Lenis-Rojas, Maria Rita Ventura, Catarina Pimentel · 2026 · Antimicrobial Agents and Chemotherapy
39. Multidrug Resistance and Host Adaptation in Candida Auris: From Molecular Mechanisms to Emerging Therapeutic Frontiers
    Fenglin Shao, Tingru Wu, Jingjing Su · 2026 · Mycopathologia
40. Inhibition of Fungal Biofilms
    Christopher G. Pierce, Anand Srinivasan, Priya Uppuluri, Anand K. Ramasubramanian, Jose Luis Lopez-Ribot · 2014 · Springer series on biofilms
41. Role of Glucan-Derived Polymers in the Pathogenic Fungus Candida albicans
    Daniel Prieto, Elvira Román, Rebeca Alonso‐Monge, Jesús Plá · 2019 · Biologically-inspired systems
42. Hsp90 as Drug Target Against Bacterial and Fungal Infections
    Mohammad Waseemul Islam, Samir Haj Bloukh, Zehra Edis, Sabrina Ait Gacem · 2020 · Current Chemical Biology
43. Microbial and Plant Natural Products and Their Antifungal Targets
    Prateek Kumar, Kapinder Kapinder, Manish Sharma, Munendra Kumar, Khyati Khyati · 2024 · Springer eBooks
44. Investigation of in vitro Antileishmanial Activity of Moxifloxacin, Linezolid and Caspofungin on Leishmania tropica Promastigotes Leishmania tropica Promastigotlari Üzerine Moksifloksasin, Linezolid ve Kaspofunginin in vitro Antileishmanial Etkisinin Araştirilmasi
    Mehmet Emin Limoncu, Bayrı Eraç, Ahmet Özbilgin, Mine Hoşgör Limoncu · 2013
45. Use of Novel Tools to Probe Drug Resistance in Fungi
    Yanan Zhao, David S. Perlin · 2017 · Springer eBooks
46. A New Marker of Echinocandin Activity in an In Vitro Pharmacokinetic/Pharmacodynamic Model Correlates with an Animal Model of Aspergillus fumigatus Infection
    Joseph Meletiadis, Maria Siopi, Athanasios Tsakris, Johan Willem Mouton, Spyros Pournaras · 2018 · Antimicrobial Agents and Chemotherapy
47. Functional Genomic and Chemical Biology Analysis of Echinocandin Resistance in Candida albicans
    Tavia Caplan · 2018 · TSpace (University of Toronto)
48. Mechanisms of Resistance to Antifungal Agents
    David S. Perlin · 2023 · ClinMicroNow
49. Hijacking the Candida albicans Multidrug Resistant Transporter MDR1 to Potentiate Antifungal Activity
    Nuo Sun · 2013 · DigitalGeorgetown (Georgetown University Library)
50. Rapid Antifungal Susceptibility Testing by Matrix-Assisted Laser Desorption Ionization Time-of- 1
    Antonietta Vella, Elena De Carolis, David S. Perlin, Brunella Posteraro, Maurizio Sanguinetti, Daltonik Bruker · 2013
51. Molecular Targets for Anticandidal Chemotherapy
    Sławomir Milewski · 2017 · Springer eBooks
52. Tolerance of yeast biofilm cells towards systemic antifungals
    Rasmus K. Bojsen · 2014
53. The Roles of Hsp90 and Calcineurin in Antifungal Drug Resistance
    Sheena Singh · 2012 · TSpace (University of Toronto)
54. The role of the FKS1 gene in nosocomial Candida albicans isolates’ virulence and antifungal resistance
    Giovanni Rodríguez-Leguizamón · 2022 · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
55. Antifungal Consideration for Transplant Recipients
    Yanina Dubrovskaya, Man Yee Merl, David S. Perlin, Amar Safdar · 2019 · Springer eBooks
56. Az antifungális rezisztencia és a virulencia összefüggésének vizsgálata Candida parapsilosis-ban
    Csaba Papp · 2019
57. Effects of Obesity and Type 2 Diabetes on the Pharmacokinetic and Pharmacodynamic Properties of AmBisome
    Ielyzaveta Slarve · 2021
58. Use of Novel Tools to Probe Drug Resistance in Fungi
    Yanan Zhao, David S. Perlin · 2014 · Springer eBooks
59. Echinocandin Resistance
    David S. Perlin · 2017 · Springer eBooks
60. Coriandrum sativum L. (coriander) essential oil
    Irlan Almeida Freires · 2014
61. Functional Structure of Biomacromolecules in Plant Biomass Using Solid-State NMR and Dynamic Nuclear Polarization
    Alex Kirui · 2021
62. A New Insight into Fungal Cell Wall Architecture by Functional Genomics and Solid-State NMR along with Recent Advancements in Dynamic Nuclear Polarization for Analyzing Biomolecules
    A. Chakraborty · 2022
63. Development of a heat-killed fbp1 mutant strain as a therapeutic agent to treat invasive Cryptococcus infection
    Yina Wang, Keyi Wang, Amariliz Rivera, Chaoyang Xue · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
64. Ação antifúngica de biocomponentes do óleo essencial de Mentha spp. sobre espécies de Candida
    Giovana Cláudia Boni · 2020
65. Introductory Chapter: Candidiasis and Antifungal Drug Resistance Feature
    Payam Behzadi · 2024 · IntechOpen eBooks
66. Deletion of core septin gene aspB in Aspergillus fumigatus results in fungicidal activity of caspofungin
    Rebecca Jean Busch, Carson Doty, Christine A. Mills, Flutur Latifi, Laura E. Herring, Vjollca H. Konjufca, Francisco Carvallo, Tatiana Boluarte, José M Vargas-Muñiz · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
67. Exploring the Antimicrobial Potential of a Peptide Against Mixed Biofilm of Staphylococcus aureus and Candida albicans
    Graziele Custódia Sandim, Janaína de Cássia Orlandi Sardi, Amanda Carolina Borges da Silva, Letícia Souza Lima, Eduardo Benedetti Parisotto, Edson Crusca, Ana Cristina Jacobowski, Maria Lı́gia Rodrigues Macedo · 2025 · Probiotics and Antimicrobial Proteins
68. Advances in Metal‐Catalyzed Buchwald–Hartwig Coupling for Bioactive Molecule Synthesis: A Review
    Muhammad Waqas, Uzma Afzal, Hasan Abbas, Aqsa Kanwal, Nasır Rasool, Sadia Nazir, Mahwish Arshad, Muhammad Imran · 2026 · ChemistrySelect
69. Etude fonctionnelle et inhibition de la protéine Bdf1 chez Candida albicans
    Morgane Champleboux · 2016 · theses.fr (ABES)
70. Emerging Antifungal Resistance in Ocular Infections
    Haroldo César de Oliveira, Aileen Miwa Tabuse, Ana Luísa Höfling-Lima, Anderson Messias Rodrigues · 2026 · Springer eBooks
71. The Biosecurity Field so Far
    Manousos E. Kambouris · 2026 · Advanced sciences and technologies for security applications
72. Thwarting the biothreat in the 21st century: means and methods
    Manousos E. Kambouris, Aristea Velegraki, George P. Patrinos · 2026 · Future Microbiology
73. Emerging antifungal agents in human medicine: Mechanisms, clinical progress, and future perspectives
    Raed M. Al‐Zoubi, Alaa Farhan, Basma Hanbali, Sally R. Al-Zoubi, Yosef R. Al-Zoubi, Mohanad Shkoor, Leena M. Alkharraz, Abdelali Agouni, Ameera Al-Jabiry · 2026 · European Journal of Medicinal Chemistry
74. Deletion of core septin gene aspB in Aspergillus fumigatus results in fungicidal activity of caspofungin
    Rebecca Jean Busch, Carson Doty, C. Allie Mills, Flutur Latifi, Laura E. Herring, Vjollca H. Konjufca, Francisco R. Carvallo, Tatiana Boluarte, José M. Vargas-Muñiz · 2026 · Molecular Biology of the Cell
75. Cell wall-targeting fungicides in tea disease control: From ergosterol biosynthesis to glucan synthase inhibition
    Nazeer Ahmed, Zhuo Chen · 2026 · Physiological and Molecular Plant Pathology
76. BindingDB Entry 50006411: Novel orally active inhibitors of β-1,3-glucan synthesis derived from enfumafungin.
    BindingDB · 2020 · UC San Diego